Results from the randomised phase III Children’s Oncology Group (COG) trial, AAML0531
Results from the randomised phase III Children’s Oncology Group (COG) trial, AAML0531
Final stage II results of the CLL11 trial
Donor-derived anti-CD19 chimeric-antigen-receptor-expressing T cells cause regression of malignancy
Equality of access to transplant for ethnic minority patients
Effective treatment of chemotherapy-refractory diffuse large B cell lymphoma
Encouraging outcomes in older patients following nonmyeloablative haploidentical blood or marrow transplantation
Immune reconstitution and preliminary safety analysis of somatic gene therapy
Immunotherapy in metastatic kidney cancer
Toxicity complications from chemotherapy in lung cancer treatment
Multidisciplinary in cancer care in India
Scientific platform for scientific data in India
Oncology organisations in India and bone health in prostate and breast cancer